{{Refimprove|date=June 2007}}
{{Infobox company
| name      = Warner Chilcott
| logo      = [[File:Warner-chilcott-logo.png|220px|Warner Chilcott]]
| type      = [[Subsidiary]]
| parent            = [[Actavis]]
| caption            = 
| foundation        = 1968
| founder           = [[Allen McClay]]
| location          = [[Rockaway, New Jersey]], United States
| area_served       = 
| key_people        = 
| industry          = [[Pharmaceutical]]
| products          = Drugs  
| revenue           = 
| num_employees     =   
| homepage          = {{URL|www.wcrx.com}} 
}}
'''Warner Chilcott''' (formerly '''Galen''') is a [[pharmaceutical]] company based in [[Rockaway, New Jersey]], United States. It has production and research facilities in [[Fajardo]], Puerto Rico, [[Larne]], Northern Ireland, [[Dundalk]], Republic of Ireland and [[Weiterstadt]], Germany. It is primarily focused on two core therapeutic areas: women’s healthcare and [[dermatology]]. The company has 2700 employees worldwide, 1700 of which are based in the United States.<ref>[http://files.shareholder.com/downloads/WCRX/1168712939x6261160x459178/E1CD37FC-80A1-412D-BDFF-9036B5D66268/WCRX_2010_AR.pdf Warner Chilcott annual report 2010]</ref> The company established its corporate headquarters in [[Dublin]], Republic of Ireland in 2010.<ref name="WCFAQ">[http://ir.wcrx.com/faq.cfm Warner Chilcott FAQ] Accessed: 2011-04-26</ref>

==History==
In 1968, the Company was founded by Sir [[Allen McClay]] as Galen, a sales and marketing organisation focused on branded pharmaceutical products in the [[United Kingdom|UK]] and [[Republic of Ireland]]. The company listed its shares on the [[London Stock Exchange]] and [[Irish Stock Exchange]].

In 2000, Galen acquired the Warner Chilcott, a US pharmaceutical company, which is focused on women’s healthcare, and simultaneously listed its [[American Depositary Receipt|ADRs]] on [[NASDAQ]]. In 2004, the company changed its name from ''Galen'' to ''Warner Chilcott''.

On October 30, 2009, Warner Chilcott closed a deal to acquire [[Procter & Gamble]]'s prescription-drug business for $3.1 billion, according to the ''Wall Street Journal''; the deal had been announced on August 24, 2009.

Warner Chilcott markets Sarafem ([[fluoxetine]] or 'Prozac') which is manufactured by [[Eli Lilly and Company]].<ref>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0cfd1880-a013-4ca0-a08f-dfd45fb2729b</ref>

On May 20, 2013, [[Actavis]] and Warner Chilcott announced that they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued at approximately $8.5 billion.<ref>[http://ir.wcrx.com/releasedetail.cfm?ReleaseID=765882 Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company]</ref>

==See also==
{{Portal|Companies}}
*[[List of Irish companies]]

==References==
{{Reflist}}

==External links==
*[http://www.wcrx.com Official website]
*[https://www.forbes.com/sites/simonking/2013/05/20/three-reasons-actavis-is-buying-warner-chilcott/ Three Reasons Actavis Is Buying Warner Chilcott]

[[Category:Companies of Northern Ireland]]
[[Category:OMERS]]
[[Category:Companies formerly listed on NASDAQ]]
[[Category:Pharmaceutical companies based in New Jersey]]


{{med-company-stub}}
{{NorthernIreland-stub}}
{{Europe-company-stub}}